Radiopharmaceutical Theranostics Market: Is 2026 the Year...

Ajouter une nouvelle offre d'emploi Health

2026-02-13 06:47:33 - Traduire

Radiopharmaceutical Theranostics Market: Is 2026 the Year "Treat What You See" Becomes the Primary Oncology Standard?

In early 2026, the Radiopharmaceutical Theranostics Market is estimated at $2.66 billion, officially crossing the threshold from "niche nuclear medicine" to a "precision oncology powerhouse." This year, the industry is buzzing over the clinical success of alpha-emitter pipelines, which use high-energy particles to destroy cancer cells with even greater precision than current beta-emitters. This...

0 Commentaires 0 Parts 135 Vue 0 Aperçu